• Users Online: 112
  • Print this page
  • Email this page
Year : 2015  |  Volume : 8  |  Issue : 2  |  Page : 183-190

Palliative and oncological management of pancreatic cancer

Department of Clinical Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK

Correspondence Address:
Rowan W Parks
Professor of Surgical Sciences, Department of Clinical Surgery, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.7707/hmj.438

Rights and Permissions

Pancreatic cancer is among the most difficult cancers to manage owing to a lack of early symptoms, early metastatic spread and debilitating cachexia quite unlike that seen in most other tumours. Up to 80% of patients will have metastatic or locally advanced disease at the time of presentation and therefore the mainstay of management in the majority of cases is symptomatic with or without the addition of systemic treatment, depending on patient factors. This review focuses on oncological strategies for advanced pancreatic cancer from standard gemcitabine-based therapies to the more recently reported molecular profiling-based strategies that are becoming the mainstay of treatment in recent years. In a disease with such a guarded prognosis, symptom management and maximizing quality of life is of utmost importance; here, we also review the multidisciplinary management of biliary obstruction, gastric outlet obstruction, pain, cachexia and the risk of thromboembolism.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded80    
    Comments [Add]    

Recommend this journal